AAAAAA

   
Results: 1-13 |
Results: 13
A RANDOMIZED TRIAL OF HIGH-DOSE VS STANDARD-DOSE MITOXANTRONE WITH CYTARABINE IN ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA
Authors: FELDMAN EJ SEITER K DAMON L LINKER C RUGO H RIES C CASE DC BEER M AHMED T
Citation: Ej. Feldman et al., A RANDOMIZED TRIAL OF HIGH-DOSE VS STANDARD-DOSE MITOXANTRONE WITH CYTARABINE IN ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Leukemia, 11(4), 1997, pp. 485-489
PULMONARY INJURY COMPLICATES THE ADDITION OF PACLITAXEL TO HIGH-DOSE ALKYLATORS AND STEM RESCUE IN PATIENTS WITH BREAST-CANCER
Authors: DAMON L RUGO H WOLF J BREED C TRIPATHY D RIES C LINKER C
Citation: L. Damon et al., PULMONARY INJURY COMPLICATES THE ADDITION OF PACLITAXEL TO HIGH-DOSE ALKYLATORS AND STEM RESCUE IN PATIENTS WITH BREAST-CANCER, Blood, 90(10), 1997, pp. 4356-4356
A PHASE-III STUDY EVALUATING CD34(-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA - ENGRAFTMENT RESULTS() SELECTED VERSUS UNSELECTED AUTOLOGOUS PERIPHERAL)
Authors: SCHILLER G STEWART AK BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANFOLO S STIFF P PINEIRO L DALTON W HO A VESCIO R BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: G. Schiller et al., A PHASE-III STUDY EVALUATING CD34(-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA - ENGRAFTMENT RESULTS() SELECTED VERSUS UNSELECTED AUTOLOGOUS PERIPHERAL), Blood, 90(10), 1997, pp. 960-960
QUALITY-OF-LIFE EVALUATION FOLLOWING 4HC PURGED AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) USING THE BUSULFAN ETOPOSIDE REGIMEN FOR ACUTE MYELOID-LEUKEMIA (AML)/
Authors: RUGO H DAMON L RIES C LINKER C
Citation: H. Rugo et al., QUALITY-OF-LIFE EVALUATION FOLLOWING 4HC PURGED AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) USING THE BUSULFAN ETOPOSIDE REGIMEN FOR ACUTE MYELOID-LEUKEMIA (AML)/, Blood, 90(10), 1997, pp. 1690-1690
MYELOMA CELL TUMOR REDUCTION IN PBPC AUTOGRAFTS FOLLOWING CD34 SELECTION - THE RESULTS OF A PHASE-III TRIAL USING THE CEPRATE DEVICE
Authors: VESCIO R STEWART A BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANTOLO S STIFF P PINERO L DALTON W HO A SCHILLER G BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: R. Vescio et al., MYELOMA CELL TUMOR REDUCTION IN PBPC AUTOGRAFTS FOLLOWING CD34 SELECTION - THE RESULTS OF A PHASE-III TRIAL USING THE CEPRATE DEVICE, Blood, 90(10), 1997, pp. 1872-1872
INCREASE IN CIRCULATING TUMOR-CELL BURDEN DURING MOBILIZATION CHEMOTHERAPY PREDICTS FOR RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA PATIENTS
Authors: VESCIO R STEWART A BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANTOLO S STIFF P PINERO L DALTON W HO A SCHILLER G BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: R. Vescio et al., INCREASE IN CIRCULATING TUMOR-CELL BURDEN DURING MOBILIZATION CHEMOTHERAPY PREDICTS FOR RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 2515-2515
THE DETECTION OF KSHV IS INCREASED BY MOBILIZATION CHEMOTHERAPY AND REDUCED IN AUTOGRAFTS BY CD34-SELECTION
Authors: VESCIO R WU C RETTIG M STEWART A BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANTOLO S STIFF P PINERO L DALTON W HO A SCHILLER G BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: R. Vescio et al., THE DETECTION OF KSHV IS INCREASED BY MOBILIZATION CHEMOTHERAPY AND REDUCED IN AUTOGRAFTS BY CD34-SELECTION, Blood, 90(10), 1997, pp. 2516-2516
IDARUBICIN, HIGH-DOSE ETOPOSIDE AND HIGH-DOSE ARA-C (IDEA) TREATMENT OF HIGH-RISK ACUTE-LEUKEMIA - A RANDOMIZED STUDY OF SCHEDULE DEPENDENCY OF ETOPOSIDE
Authors: JOHNSTON L DAMON L RIES C RUGO H LINKER C
Citation: L. Johnston et al., IDARUBICIN, HIGH-DOSE ETOPOSIDE AND HIGH-DOSE ARA-C (IDEA) TREATMENT OF HIGH-RISK ACUTE-LEUKEMIA - A RANDOMIZED STUDY OF SCHEDULE DEPENDENCY OF ETOPOSIDE, Blood, 88(10), 1996, pp. 855-855
QUANTITATIVE ASSESSMENT OF MYELOMA PERIPHERAL-BLOOD AND BONE-MARROW TUMOR BURDEN IN PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION
Authors: VESCIO RA SCHILLER GJ STEWART AK ANDERSON KC DIPERSIO JF NOGA SJ BALLESTER OF RUGO H FREYTES CO WU CH HAN EJ CAO J BELSON DJ BERENSON JR
Citation: Ra. Vescio et al., QUANTITATIVE ASSESSMENT OF MYELOMA PERIPHERAL-BLOOD AND BONE-MARROW TUMOR BURDEN IN PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION, Blood, 88(10), 1996, pp. 2551-2551
SINGLE DAY LARGE-VOLUME LEUKAPHERESIS FOLLOWING STANDARD-DOSE CHEMOTHERAPY FOR BREAST-CANCER IS ADEQUATE FOR TRANSPLANTATION
Authors: RUGO H DAMON L RIES C LINKER C
Citation: H. Rugo et al., SINGLE DAY LARGE-VOLUME LEUKAPHERESIS FOLLOWING STANDARD-DOSE CHEMOTHERAPY FOR BREAST-CANCER IS ADEQUATE FOR TRANSPLANTATION, Blood, 86(10), 1995, pp. 1618-1618
DOSE MODIFICATION REDUCES THE INCIDENCE OF HIGH-DOSE ARA-C (HDAC) NEUROTOXICITY IN PATIENTS WITH RENAL-INSUFFICIENCY
Authors: SMITH G DAMON L RUGO H RIES C LINKER C
Citation: G. Smith et al., DOSE MODIFICATION REDUCES THE INCIDENCE OF HIGH-DOSE ARA-C (HDAC) NEUROTOXICITY IN PATIENTS WITH RENAL-INSUFFICIENCY, Blood, 84(10), 1994, pp. 10000146-10000146
TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) WITH SUBCUTANEOUS 5-AZACYTIDINE (AZA C)
Authors: RUGO H DAMON L RIES C LINKER C
Citation: H. Rugo et al., TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) WITH SUBCUTANEOUS 5-AZACYTIDINE (AZA C), Blood, 84(10), 1994, pp. 10000317-10000317
AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) FOR NON-HOGKINS (NHL) AND HODGKINS (HD) LYMPHOMA USING A THIOTEPA-BASED PREPARATIVE REGIMEN
Authors: DAMON L WOLF I RUGO H RIES C TRACEY M CECCHI G GOLD E LINKER C
Citation: L. Damon et al., AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) FOR NON-HOGKINS (NHL) AND HODGKINS (HD) LYMPHOMA USING A THIOTEPA-BASED PREPARATIVE REGIMEN, Blood, 84(10), 1994, pp. 10000706-10000706
Risultati: 1-13 |